Loading...
Amarin Corporation plc
AMRN•NASDAQ
Healthcare
Biotechnology
$15.39
$-0.11(-0.71%)
Amarin Corporation plc (AMRN) Financial Performance & Income Statement Overview
Review Amarin Corporation plc’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
-25.51%
↓ 25.51%
Operating Income Growth
-35.82%
↓ 35.82%
Net Income Growth
-39.03%
↓ 39.03%
Operating Cash Flow Growth
-551.06%
↓ 551.06%
Operating Margin
-44.34%
↓ 44.34%
Gross Margin
34.50%
↑ 34.50%
Net Profit Margin
-41.05%
↓ 41.05%
ROE
-17.21%
↓ 17.21%
ROIC
-19.25%
↓ 19.25%
Amarin Corporation plc (AMRN) Income Statement & Financial Overview
Review Amarin Corporation plc's (AMRN) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $62.31M | $42.30M | $67.57M | $56.49M |
| Cost of Revenue | $71.87M | $26.02M | $25.51M | $25.36M |
| Gross Profit | -$9.57M | $16.28M | $42.06M | $31.12M |
| Gross Profit Ratio | -$0.15 | $0.38 | $0.62 | $0.55 |
| R&D Expenses | $5.99M | $4.54M | $3.99M | $4.83M |
| SG&A Expenses | $36.97M | $36.90M | $38.59M | $39.87M |
| Operating Expenses | $42.95M | $41.44M | $42.58M | $44.70M |
| Total Costs & Expenses | $114.83M | $67.47M | $68.09M | $70.06M |
| Interest Income | $3.38M | $3.37M | $3.27M | $3.38M |
| Interest Expense | $7000.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $737000.00 | $760722.00 | $761853.00 | $761564.00 |
| EBITDA | -$37.18M | -$24.41M | $237000.00 | -$12.82M |
| EBITDA Ratio | -$0.60 | -$0.58 | $0.004 | -$0.23 |
| Operating Income | -$52.52M | -$25.17M | -$524590.00 | -$13.58M |
| Operating Income Ratio | -$0.84 | -$0.60 | -$0.008 | -$0.24 |
| Other Income/Expenses (Net) | $2.62M | $3.42M | $3.42M | $4.93M |
| Income Before Tax | -$49.91M | -$21.75M | $2.90M | -$8.65M |
| Income Before Tax Ratio | -$0.80 | -$0.51 | $0.04 | -$0.15 |
| Income Tax Expense | -$1.29M | $3.60M | $1.37M | $1.30M |
| Net Income | -$48.62M | -$25.13M | $1.52M | -$9.95M |
| Net Income Ratio | -$0.78 | -$0.59 | $0.02 | -$0.18 |
| EPS | -$0.12 | -$0.06 | $0.004 | -$0.02 |
| Diluted EPS | -$0.12 | -$0.06 | $0.004 | -$0.02 |
| Weighted Avg Shares Outstanding | $20.56M | $411.15M | $410.85M | $410.15M |
| Weighted Avg Shares Outstanding (Diluted) | $20.56M | $411.15M | $411.39M | $410.15M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan